UNSPSC 51433404: Quinaprilat

This classification denotes an ace inhibitor with the molecular formula C23H26N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34SSX5LDE5, chemically known as 3-isoquinolinecarboxylic acid, 2-((2s)-2-(((1s)-1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3s)- but generally known as quinaprilat, which bears US NIH Compound Identifier 107994. European Medicines Agency schedules Quinaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10202MIG.

UNSPSC 51433404 Quinaprilat, a Commodity code, represents injectable cardiovascular medications that state and local governments procure for emergency medical services and public health programs. State and local buyers under this code include municipal fire rescue departments, state health agencies, and cooperative purchasing alliances serving multi-state government networks. The scope of work encompasses supply of branded or generic injectable medications meeting FDA manufacturing standards, expiration and shelf-life requirements, and OSHA safety documentation; procurement typically specifies unit quantities, delivery timelines, and warranty obligations for product defects and expired-stock replacement.

The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (IFB 26P00188) with a response date of April 8, 2026, for Tampa Fire Rescue in Hillsborough County, Florida, requesting 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with an estimated contract value of $40,000.00 and a one-year term plus optional renewals. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) with a response date of March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, including Oregon, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) with a contract term of two years. Recent activity reflects procurement spread across municipal and state purchasing bodies in Florida and the upper Midwest, though the broader geographic distribution and volume of activity under this specific code remain limited in the available record.